Delivery Order SPE2DU25D9415-SPE2DU26FEJCS
Award Date 4/10/26
Potential Completion Date 4/13/26
Potential Value $21K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 20, 2026, with a ceiling value of $14,837.67 for pharmaceutical products under firm fixed-price terms, with an ultimate completion date of March 23, 2026. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price calls for branded and generic prescription drugs,...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 9, 2026, with a ceiling value of $35,377.28 for pharmaceutical products under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the PPV-G GEN V, a Defense Logistics Agency single-award indefinite delivery contract (ceiling $499,999,999, completion December 31, 2036) that authorizes firm...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 10, 2026, for pharmaceutical products under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), with a ceiling value of $4,361.95. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler. The order is placed against the company's single-award Indefinite Delivery Contract under the Defense Logistics Agency's PPV-G GEN V initiative, a $499.999 billion...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on March 13, 2026, for pharmaceutical products under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), with a ceiling value of $11,771.46. DMS Pharmaceutical Group holds a single-award indefinite delivery contract under PPV-G GEN V, awarded November 13, 2025, with a $499.999 billion ceiling and an...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 9, 2026, with a ceiling value of $87,455.90 for pharmaceutical products under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the PPV-G GEN V, a Defense Logistics Agency indefinite delivery contract that authorizes firm fixed-price delivery orders for branded and generic prescription...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on March 16, 2026, with a ceiling value of $11,844.88 for pharmaceutical products. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a DLA indefinite delivery contract with a $499,999,999 ceiling and completion date of December 31, 2036. PPV-G GEN V is a multi-regional prime vendor acquisition strategy...
- The Defense Logistics Agency issued a $12,673.12 delivery order to DMS Pharmaceutical Group Inc. on April 8, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products to support Department of Defense medical supply needs. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract established under a $30.3 billion governmentwide...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 8, 2026, with a ceiling value of $163,578.35 for pharmaceutical products under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the Defense Logistics Agency's single-award Indefinite Delivery Contract SPE2DR, which carries a $499,999,999 ceiling and runs through December 31, 2036. PPV-G...
- The Defense Logistics Agency issued a $17,539.03 delivery order to DMS Pharmaceutical Group Inc. on April 1, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical distribution. DMS Pharmaceutical Group Inc. is a woman-owned small business. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide, with a program ceiling of $30.3 billion...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on February 5, 2026, with a ceiling value of $3,691.14 for pharmaceutical products. This delivery order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award Indefinite Delivery Contract with a $499,999,999 ceiling that authorizes DLA to procure branded and generic prescription...